Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 112 entries
Sorted by: Best Match Show Resources per page
The effect of glucose and insulin infusion on the fall of ketone bodies during treatment of diabetic ketoacidosis.

Diabetic medicine : a journal of the British Diabetic Association

Krentz AJ, Hale PJ, Singh BM, Nattrass M.
PMID: 2522371
Diabet Med. 1989 Jan-Feb;6(1):31-6. doi: 10.1111/j.1464-5491.1989.tb01135.x.

During the treatment of diabetic ketoacidosis intravenous glucose is infused when blood glucose has fallen to around 14 mmol l-1. The use of hypertonic (10%) glucose has been recommended in order to hasten the clearance of blood ketone bodies....

Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation.

Diabetes, obesity & metabolism

Dmitrewski J, Krentz AJ, Mayer AD, Buckels JA, Barnes AD, Smith J, Nattrass M.
PMID: 11520309
Diabetes Obes Metab. 2001 Aug;3(4):287-92. doi: 10.1046/j.1463-1326.2001.00132.x.

Twelve renal transplant recipients randomised to receive immunosuppression with either tacrolimus (FK506) or cyclosporin underwent oral glucose tolerance tests (OGTT) a median of 8 months (range 7-9) after transplantation. Six healthy subjects acted as controls. Compared with the controls,...

Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.

Drug safety

Evans A, Krentz AJ.
PMID: 10433350
Drug Saf. 1999 Jul;21(1):7-22. doi: 10.2165/00002018-199921010-00002.

The treatment of type 2 diabetes mellitus remains controversial. Since most patients are overweight or obese, regimens based on dietary modification and increased physical exercise are logical and safe treatment approaches. However, the long term impact of these interventions...

Controversy in thyroid disease.

Journal of the Royal College of Physicians of London

Krentz AJ.
PMID: 11077671
J R Coll Physicians Lond. 2000 Sep-Oct;34(5):502.

No abstract available.

Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex.

Journal of acquired immune deficiency syndromes

Krentz AJ, Koster FT, Crist DM, Finn K, Johnson LZ, Boyle PJ, Schade DS.
PMID: 8450399
J Acquir Immune Defic Syndr (1988). 1993 Mar;6(3):245-51.

Metabolic and anthropometric changes induced by "pharmacological" versus "physiological" doses (5.0 vs. 2.5 mg, every other day) of recombinant human growth hormone (rhGH) were compared in 10 human immunodeficiency virus-positive patients with AIDS or AIDS-related complex. Five patients were...

Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506.

The Journal of laboratory and clinical medicine

Krentz AJ, Cramb R, Dousset B, Mayer D, McMaster P, Buckels J, Smith JM, Nattrass M.
PMID: 7521895
J Lab Clin Med. 1994 Sep;124(3):381-5.

The immunosuppressive agent cyclosporin A (CsA) is reportedly associated with clinically adverse effects on circulating lipid and apolipoprotein concentrations. To date few data have been reported concerning the effects on lipid metabolism of the new macrolide immunosuppressive agent FK...

Hyperthyroidism associated with hyperemesis gravidarum.

The British journal of clinical practice

Krentz AJ, Redman H, Taylor KG.
PMID: 8024995
Br J Clin Pract. 1994 Mar-Apr;48(2):75-6.

Hyperemesis gravidarum is an uncommon presentation of hyperthyroidism in pregnancy which is usually attributable to autoimmune (Graves') disease. While this condition necessitates treatment with antithyroid drugs, a syndrome of transient hyperthyroidism associated with hyperemesis gravidarum that resolves spontaneously is...

Should cisapride be avoided in patients with diabetic gastroparesis?.

Journal of diabetes and its complications

Evans AJ, Krentz AJ.
PMID: 10765008
J Diabetes Complications. 1999 Sep-Dec;13(5):314-5. doi: 10.1016/s1056-8727(99)00058-6.

The gastrointestinal motility stimulants, cisapride and erythromycin, have been used in the management of diabetic gastroparesis. However, drug interactions may result in prolongation of the electrocardiographic QT interval with the risk of ventricular arrhythmias. These drugs should, therefore, not...

Iatrogenic recurrent severe hypercalcaemia and renal impairment.

Postgraduate medical journal

Sulkin T, Krentz AJ.
PMID: 11085785
Postgrad Med J. 2000 Dec;76(902):802D. doi: 10.1136/pmj.76.902.802c.

No abstract available.

New drugs for type 2 diabetes mellitus: what is their place in therapy?.

Drugs

Krentz AJ, Patel MB, Bailey CJ.
PMID: 18840004
Drugs. 2008;68(15):2131-62. doi: 10.2165/00003495-200868150-00005.

Oral therapy for type 2 diabetes mellitus, when used appropriately, can safely assist patients to achieve glycaemic targets in the short to medium term. However, the progressive nature of type 2 diabetes usually requires a combination of two or...

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Drugs

Krentz AJ, Bailey CJ.
PMID: 15669880
Drugs. 2005;65(3):385-411. doi: 10.2165/00003495-200565030-00005.

Type 2 diabetes mellitus is a progressive and complex disorder that is difficult to treat effectively in the long term. The majority of patients are overweight or obese at diagnosis and will be unable to achieve or sustain near...

New-onset diabetes after transplantation: a threat to graft and patient survival.

Lancet (London, England)

Krentz AJ, Wheeler DC.
PMID: 15721460
Lancet. 2005 Feb 19-25;365(9460):640-2. doi: 10.1016/S0140-6736(05)17962-8.

No abstract available.

Showing 1 to 12 of 112 entries